scroll

Clarity Pharmaceuticals (CU6)

Advanced Search

Our Q&As are emailed in our Saturday Morning Report, find the answer to this question below.

Ask a question

The Latest Q&A

Question asked 26/07/2025

Clarity Pharmaceuticals (CU6)

Clarity Pharma (CU6) has kicked up in the last month or two and I bought a small parcel which has done well. Broker consensus was positive at the time but where to from here? Do we take the money and run? Let it ride? What would you do? and do you think long term it could become a 10 bagger so to speak thanks for the service, a must read each day are your comments for me.

Answer

Hi Peter,

Clarity Pharma (CU6) is a volatile beast; it was up around 10% when we were answering this question on Thursday, although it’s still down marginally year-to-date, and 50% below its 12-month high. The stock’s recent strength has come following a broker note suggesting the market for its SAR-bisPSMA imaging agent is larger than investors initially thought – Canaccord raised their forecast for sales from the next three to five years to $US730 million, from $US520 million previously.

However, not everyone is so keen on CU6 with the stock attracting the biggest percentage increase in total bearish bets for the week ending 7th of July. Hence, at this stage of its evolution we regard CU6 as trading/aggressive investment vehicle with the $1.4bn business still losing money – at the end of the March quarter they had total available cash of ~$106mn providing runway into the second half of 2026.

From a trading perspective we like CU6 while it holds above $3 although with resistance coming in ~$4.50 we can see some consolidation in the coming weeks.

If we had to put a label on CU6 at $4.30 it would be neutral.

chart

Clarity Pharmaceuticals (CU6)

LAST UPDATED 24/07/2025 15:34

Latest Reports

Weekend report 26/07/2025

CORRECTWeekend Q&A: The ASX200 is feeling “soft” as we approach August & September

The ASX200 slipped 1% last week, eroding 40% of July's gains as the RBA took the shine off the local market even as global indices pushed to fresh highs, i.e. the US S&P 500 advanced +1.5% last week. The S&P 500 notched its 5th straight record weekly closing high, courtesy of more than 80% of the 169 S&P 500 companies that have reported to date have beaten Wall Street’s expectations. In Australia, it's been a more mixed and polarised affair on the reporting front, but with the “Big Four Banks” retreating on average close to 4% the ASX was always going to struggle to match its overseas peers.

Afternoon report 25/07/2025

The Match Out: Stocks end the week lower; Resources join Banks in the sell-off

The ASX put in a weaker session seeing sustained selling through the day, as softer iron ore prices weighed on the materials space. With heavyweight resources and the big banks down, the index was fighting a losing battle from start to finish, though we still managed to close higher for the week.